Saturday 10 October 2026 Export all MRK data to Excel Powerpack

Merck & Co., Inc.

MRK Healthcare Drug Manufacturers General

Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS fell 130.7%, free cash flow grew 77.0% and total debt rose 50.4%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for five.

145.60 3.22 +2.26%

Follow MRK

Alert me

Market cap: $351.3B
P/E: 116×
Fwd P/E: 53.9×
Dividend yield: 2.34%
F-score: 4/9
Altman Z: 3.77
Beneish M: −2.27
Dividend safety: 74/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	102.80	33.88	14.46	11.09	+8 more quarters Free account
P/S ratio Full definition →	4.77	4.52	4.05	3.26
P/FCF ratio Full definition →	19.76	21.07	21.31	16.05
P/Operating CF Full definition →	59.11	75.90	92.18	26.77
P/B ratio Full definition →	7.56	6.47	5.00	4.03
Price to Tangible BV Full definition →	0.00	0.00	59.83	13.95
EV/Sales Full definition →	5.43	5.14	4.55	3.60
EV/EBITDA Full definition →	26.38	17.60	10.58	8.57
EV/Operating CF Full definition →	18.10	18.91	17.94	13.55
EV/FCF Full definition →	22.49	23.97	23.91	17.71
Quick Ratio Full definition →	0.71	0.66	0.93	1.06
Current Ratio Full definition →	1.32	1.30	1.54	1.66
Net Debt/EBITDA Full definition →	38.21	(24.26)	4.93	2.82
Debt/Assets Full definition →	39.35%	36.27%	34.16%	30.85%
Debt/Equity Full definition →	1.22	1.02	0.89	0.77
Asset Turnover Full definition →	0.54	0.54	0.51	0.52
Operating CF/Net income Full definition →	(4.02)	(0.92)	0.96	1.35
Capex/Depreciation Full definition →	(0.56)	(0.66)	(0.42)	(0.86)
Research and Development Expense of Revenue Full definition →	58.66%	77.32%	23.70%	24.51%
Selling, General and Administrative Expense of Revenue Full definition →	17.49%	16.58%	17.68%	15.24%
Intangible Assets out of Total Assets Full definition →	0.36	0.37	0.35	0.28
Share Based Compensation of Revenue Full definition →	1.79%	1.14%	1.25%	1.18%
Graham Net Nets Full definition →	(0.16)	(0.16)	(0.15)	(0.14)
Graham Number Full definition →	21.86	38.52	58.72	59.53
Earnings Yield Full definition →	0.97%	2.95%	6.92%	9.02%
Free Cash Flow Yield Full definition →	5.06%	4.75%	4.69%	6.23%
Revenue per Share Full definition →	6.72	6.59	6.55	6.92
Operating CF per Share Full definition →	2.17	1.59	1.14	3.14
Capex per Share Full definition →	(0.36)	(0.40)	(0.41)	(0.40)
Free Cash Flow per Share Full definition →	1.81	1.18	0.73	2.74
Cash per Share Full definition →	2.89	2.31	5.82	7.30
Shareholders Equity per Share Full definition →	17.00	18.58	21.05	20.80
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	17.00	18.58	21.05	20.80
Free Cash Flow Full definition →	4,477.00	2,927.00	1,824.00	6,835.00
Working Capital Full definition →	8,948.00	8,070.00	15,189.00	18,929.00
Capital Expenditures Full definition →	(893.00)	(991.00)	(1,033.00)	(987.00)
Net Current Asset Value Full definition →	(51,139.00)	(47,739.00)	(40,688.00)	(30,082.00)
EV/EBIT Full definition →	51.74	26.09	13.37	10.32
Capex to Sales Full definition →	0.05	0.06	0.06	0.06
Price to Operating Income Full definition →	45.45	22.93	11.91	9.35
Other line items
Average Receivables Full definition →	12,205.00	11,500.00	11,026.50	11,750.50
Average Payables Full definition →	3,859.50	3,823.50	4,241.50	3,866.50
Average Inventory Full definition →	6,404.00	6,337.50	6,383.50	6,344.00
Average Assets Full definition →	123,662.50	121,903.50	126,986.00	123,539.00
Average Common Equity Full definition →	45,522.00	47,165.50	49,517.00	48,233.50

Show all line items

Columns are period end dates

Stockrow Weekly